...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Corporate Update Webcast... 11:00 MT/1:00 ET... Link-->
Thanks Bear for a quick reply ! I'm curious if the two companies have separated specifically all molecules held in house ( if intellectual property hasn't been finalized between them maybe a reason for such along time for reorganization delays?) Appreciate Stock ...
Share
New Message
Please login to post a reply